Should Janus Henderson Small Cap Growth Alpha ETF (JSML) Be on Your Investing Radar?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 21 2024
0mins
Source: NASDAQ.COM
Overview of Janus Henderson Small Cap Growth Alpha ETF (JSML): Launched in 2016, JSML is a passively managed ETF focusing on small-cap growth stocks with assets over $242 million. It has an expense ratio of 0.30% and a current return of approximately 12.93% for the year.
Investment Considerations: While small-cap growth stocks offer high potential returns, they also come with higher risks. Investors should consider the ETF's holdings, sector allocations, and compare it with similar ETFs like iShares Russell 2000 Growth ETF and Vanguard Small-Cap Growth ETF for better investment decisions.
Analyst Views on DOCS
Wall Street analysts forecast DOCS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DOCS is 62.75 USD with a low forecast of 50.00 USD and a high forecast of 82.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
10 Buy
4 Hold
1 Sell
Moderate Buy
Current: 39.850
Low
50.00
Averages
62.75
High
82.00
Current: 39.850
Low
50.00
Averages
62.75
High
82.00
About DOCS
Doximity, Inc. provides a digital platform for the United States medical professionals. It offers marketing, hiring, and workflow solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and other healthcare companies. Its marketing solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from its network of both active and passive medical professional candidates, who might otherwise be missed through traditional recruiting channels. Its workflow solutions include its telehealth, on-call scheduling, and AI-powered workflow tools, are designed to help clinicians streamline their clinical workflow, reduce their administrative burden, and connect with patients and colleagues.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
